Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €76.51 EUR
Change Today 0.00 / 0.00%
Volume 0.0
LLY On Other Exchanges
New York
SIX Swiss Ex
Sao Paulo
EN Paris
As of 8:43 AM 07/27/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by ELI LILLY & CO (LLY) in the last 6 months

Announced 07/16/15
205.00M for Immunocore Limited
Private Placement

Immunocore Limited announced that it has received £205 million in its series A round of funding led by new investor, Malin Corporation plc on July 16, 2015. The oversubscribed transaction included participation from other new investors, Woodford Investment Management LLP, Eli Lilly and Company and RTW Investments, LLC and other new and existing investors. Malin Corporation plc invested £51,170,200 ($80,000,000) in the transaction. As part of the transaction, Adrian Howd, ...
Read More

LLY's price was unchanged after the transaction was announced on 07/16/15.
Investor / Buyer
Eli Lilly and Company
Malin Corporation plc
RTW Investments, LLC
Woodford Investment Management LLP
Legal Advisor
Cooley LLP
Announced 05/14/15
4.00M for Companion Medical, Inc.
Private Placement

Companion Medical, Inc. announced that it will receive $3,500,000 in equity funding on May 14, 2015. The company will issue securities pursuant to exemption provided under Regulation D. On May 20, 2015, the company received $3,170,000 in first tranche in its series B round of funding led by new investor Eli Lilly and Company. The round included participation from three investors. As a part of the round, one representative of Eli Lilly and Company will join the company’s ...
Read More

LLY's price was unchanged after the transaction was announced on 05/14/15.
Investor / Buyer
Eli Lilly and Company
Announced 05/11/15
30.00M for BioNTech Cell & Gene Therapies GmbH
Private Placement

Cell & Gene GmbH announced that it will receive $30 million in equity funding from new investor, Eli Lilly and Company on May 11, 2015. Jochen of Freshfields Bruckhaus Deringer acted as a legal advisor to the company.

LLY's price was unchanged after the transaction was announced on 05/11/15.
Investor / Buyer
Eli Lilly and Company
Legal Advisor
Freshfields Bruckhaus Deringer (Germany)

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:FP €76.51 EUR 0.00

LLY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $50.69 USD -0.08
AbbVie Inc $70.01 USD -0.15
Bristol-Myers Squibb Co $65.64 USD +1.18
Medtronic PLC $78.39 USD +0.11
Teva Pharmaceutical Industries Ltd $69.02 USD -0.05
View Industry Companies

Industry Analysis


Industry Average

Valuation LLY Industry Range
Price/Earnings 43.9x
Price/Sales 4.6x
Price/Book 6.1x
Price/Cash Flow 45.5x
TEV/Sales 4.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at